Levemir (tn) is produced through genetic engineering to generate insulin precursors, followed by subsequent protein modifications. It is primarily produced by the secretion and expression of recombinant Levemir (tn) precursors by Saccharomyces cerevisiae, which are then chemically modified with enzymatic cleavage and 14-carbon fatty acids to obtain the correctly conformated Levemir (tn).
